from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2923c/-

LFCtreatmentdescriptionclass of inhibitor

-0.455

Amikacinug/mL Amikacintranslation

-0.833

Cap5-10ug/mL Capreomycintranslation

-2.059

Rox10-50 ug/mL Roxithromycintranslation

-0.411

SM2-5 ug/mL Streptomycintranslation

-1.773

Tet5-10 ug/mL Tetracyclinetranslation

1.317

Rif0.2-5ug/mL Rifampicintranscription

-0.387

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.948

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.356

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.082

CPZ10-50 ug/mL Chlorpromazinerespiration

0.140

Clofazimine10-13 ug/mL Clofaziminerespiration

0.028

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.363

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.187

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.124

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.808

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.013

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.719

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.505

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.246

KCN5-20 ug/mL Potassium cyaniderespiration

0.711

NaN30.2-2 mM Sodium aziderespiration

0.069

Nigericin50 uM Nigericinrespiration

0.518

TRC10-150 ug/mL Triclosanrespiration

0.562

TRZ10-25 ug/mL Thioridazinerespiration

-1.153

Valinomycin0.5-10 uM Valinomycinrespiration

0.677

ZnSO42 mM ZnSO4respiration

-0.091

menadione6-10 ug/mL Menadionerespiration

-0.006

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.299

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.170

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.086

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.280

NRP_1Non-replicating persistence stage 1dosRassociated

-0.208

Amp0.2mg/mL AmpicillincellWall

-0.233

Cephalexin20-100 ug/mL CephalexincellWall

-0.240

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.106

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.221

EMB10-20 ug/mL EthambutolcellWall

0.022

Eta12-40 ug/mL EthionamidecellWall

0.044

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.335

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.209

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.133

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.386

BZA0.12 mg/mL BenzamidearomaticAmides

0.507

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.259

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.503

H2O24 mM hydrogen peroxideDNAdamaging

0.411

Levo10 ug/mL LevofloxacinDNAdamaging

-0.359

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.350

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.546

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.170

UVUV-irradiationDNAdamaging

1.160

ARP41-4 ug/mL Antitubercular compound ARP4?

0.296

Antimycin12.5-50 ug/mL Antimycin A?

0.752

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.116

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.036

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.224

PA8240.2-2 ug/mL PA-824?

0.540

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.868

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.079

Verapamil50 uM Verapamil?

0.272

mercaptoethanol2 mM 2-Mercaptoethanol?

0.400

methoxatin10-20 ug/mL Methoxatin?